Loss of Cpt1a results in elevated glucose-fueled mitochondrial oxidative phosphorylation and defective hematopoietic stem cells.
Li J, Bai J, Pham VT, Hashimoto M, Sezaki M, Shi Q, Jin Q, He C, Armstrong A, Li T, Pan M, Liu S, Luan Y, Zeng H, Andreassen PR, Huang G.
Li J, et al. Among authors: he c.
J Clin Invest. 2025 Jan 9:e184069. doi: 10.1172/JCI184069. Online ahead of print.
J Clin Invest. 2025.
PMID: 39786963